X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse IPCA Labs with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs TEVA PHARMA (Israel) - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   TEVA PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-17
TEVA PHARMA
Dec-13
IPCA LABS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6432,674-   
Low Rs5032,323-   
Sales per share (Unadj.) Rs254.41,534.8-  
Earnings per share (Unadj.) Rs16.195.9-  
Cash flow per share (Unadj.) Rs29.8219.9-  
Dividends per share (Unadj.) Rs1.0083.93-  
Dividend yield (eoy) %0.23.4 5.2%  
Book value per share (Unadj.) Rs194.61,704.9-  
Shares outstanding (eoy) m126.20848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.31.6 138.3%   
Avg P/E ratio x35.726.1 136.8%  
P/CF ratio (eoy) x19.211.4 169.4%  
Price / Book Value ratio x2.91.5 200.9%  
Dividend payout %6.287.5 7.1%   
Avg Mkt Cap Rs m72,3002,118,923 3.4%   
No. of employees `00013.344.9 29.6%   
Total wages/salary Rs m6,9600-   
Avg. sales/employee Rs Th2,413.528,958.0 8.3%   
Avg. wages/employee Rs Th523.20-   
Avg. net profit/employee Rs Th152.41,809.0 8.4%   
INCOME DATA
Net Sales Rs m32,1061,301,518 2.5%  
Other income Rs m2260-   
Total revenues Rs m32,3321,301,518 2.5%   
Gross profit Rs m4,448356,421 1.2%  
Depreciation Rs m1,730105,203 1.6%   
Interest Rs m24125,564 0.9%   
Profit before tax Rs m2,703225,655 1.2%   
Minority Interest Rs m01,025 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-148,130 0.0%   
Tax Rs m675-2,755 -24.5%   
Profit after tax Rs m2,02881,305 2.5%  
Gross profit margin %13.927.4 50.6%  
Effective tax rate %25.0-1.2 -2,045.9%   
Net profit margin %6.36.2 101.1%  
BALANCE SHEET DATA
Current assets Rs m17,340879,040 2.0%   
Current liabilities Rs m9,559766,598 1.2%   
Net working cap to sales %24.28.6 280.5%  
Current ratio x1.81.1 158.2%  
Inventory Days Days10091 110.5%  
Debtors Days Days5796 59.3%  
Net fixed assets Rs m20,779425,104 4.9%   
Share capital Rs m2523,204 7.9%   
"Free" reserves Rs m24,4990-   
Net worth Rs m24,5531,445,740 1.7%   
Long term debt Rs m3,517665,495 0.5%   
Total assets Rs m39,5952,974,386 1.3%  
Interest coverage x12.29.8 124.4%   
Debt to equity ratio x0.10.5 31.1%  
Sales to assets ratio x0.80.4 185.3%   
Return on assets %5.73.6 159.5%  
Return on equity %8.35.6 146.9%  
Return on capital %10.54.9 212.7%  
Exports to sales %48.60-   
Imports to sales %14.20-   
Net fx Rs m9,7900-   
CASH FLOW
From Operations Rs m2,764207,395 1.3%  
From Investments Rs m-1,432-73,488 1.9%  
From Financial Activity Rs m-1,591-248,784 0.6%  
Net Cashflow Rs m-259-114,878 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.07 Rs / USD

Compare IPCA LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare IPCA LABS With: SANOFI INDIA  DISHMAN PHARMA  ALEMBIC LTD  FULFORD INDIA  NATCO PHARMA  



Today's Market

Flat Finish to the Week; Cadila Healthcare Rallies 7%(Closing)

Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks, software stocks and capital good stocks.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS